Free Trial

Innoviva (INVA) Earnings Date, Estimates & Call Transcripts

Innoviva logo
$19.56
-0.15 (-0.76%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 6Estimated
Actual EPS
(Jul. 31)
$0.68 Beat By $0.68
Skip Charts & View Estimated and Actual Earnings Data

INVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Innoviva Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.50 EPS

INVA Earnings Date and Information

Innoviva last announced its earnings results on July 31st, 2024. The biotechnology company reported $0.68 EPS for the quarter. The business earned $99.90 million during the quarter. Innoviva has generated $1.65 earnings per share over the last year ($1.65 diluted earnings per share) and currently has a price-to-earnings ratio of 11.9. Innoviva has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off prior year's report dates.

Innoviva Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/6/2024
(Estimated)
------- 
7/31/2024Q2 2024-$0.68+$0.68$1.91-$99.90 million  
5/8/2024Q1 2024-$0.46+$0.46$0.46-$77.50 million  
2/29/2024Q4 2023-$0.76+$0.76$0.76-$85.84 million  
11/1/2023Q3 2023-$0.98+$0.98$0.98-$67.26 million  
8/2/2023Q2 2023-$0.08+$0.08$0.14-$80.99 million  
5/9/2023Q1 2023-$0.42+$0.42$0.42$68.04 million$76.37 million  
2/28/2023Q4 2022$0.41$0.25($0.16)$1.48$98.31 million$65.80 million
11/9/2022Q3 2022$2.75$0.60($2.15)($1.60)$361.45 million$67.26 million  
7/27/2022Q2 2022$0.55$0.05($0.50)$0.05$103.42 million$108.22 million  
4/27/2022Q1 2022$0.40$0.42+$0.02$0.64$51.13 million$90.06 million  
2/9/2022Q4 2021$0.41$0.55+$0.14$0.96-$107.68 million  
10/27/2021Q3 2021$0.43$0.90+$0.47$0.90-$97.86 million  
7/28/2021Q2 2021$0.29$0.90+$0.61$0.90-$100.81 million  
4/28/2021Q1 2021($0.01)$0.84+$0.85$0.84-$85.52 million  
2/3/2021Q4 2020$0.40$0.48+$0.08$0.48-$90.48 million
10/28/2020Q3 2020$0.42$0.26($0.16)$0.66-$88.69 million
7/29/2020Q2 2020$0.32$0.69+$0.37$0.69-$78.95 million
4/29/2020Q1 2020$0.36$0.59+$0.23$0.59-$78.68 million
2/5/2020Q4$0.4950$0.42($0.0750)$0.42-$75.97 million

Innoviva Earnings - Frequently Asked Questions

When is Innoviva's earnings date?

Innoviva has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates. Learn more on INVA's earnings history.

How much revenue does Innoviva generate each year?

Innoviva (NASDAQ:INVA) has a recorded annual revenue of $330.50 million.

How much profit does Innoviva generate each year?

Innoviva (NASDAQ:INVA) has a recorded net income of $179.72 million. INVA has generated $1.65 earnings per share over the last four quarters.

What is Innoviva's price-to-earnings ratio?

Innoviva (NASDAQ:INVA) has a trailing price-to-earnings ratio of 11.85 and a forward price-to-earnings ratio of 39.12.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:INVA) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners